DISPLAY SOFTWARE TO EXPLORE TIME-ORIENTED CLINICAL DATA

显示软件以探索面向时间的临床数据

• 批准号: 3500045
• 负责人: Channing H Russell
• 金额: $ 4.98万
• 依托单位: BELMONT RESEARCH, INC.
• 依托单位国家: 美国
• 财政年份: 1993
• 资助国家: 美国
• 起止时间: 1993-04-01 至 1993-09-30
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/3500045
• 关键词: computer graphics /printing; computer human interaction; computer program /software; computer system design /evaluation; human data; information display; patient /disease registry; premature infant human

The primary goal of this research is to develop a specialized software tool to help the clinical investigator explore complex, time-oriented clinical data. In Phase I, we plan to collaborate with investigators from the Developmental Epidemiology Network to select data analysis, summarization, and display techniques appropriate to their research, to implement these techniques in prototype form and evaluate their utility in connection with a large database of measurements on pre-term newborns. The major technical innovation in this project is expected to be the development of an object-oriented software system that can handle the full complexity of clinical data and give the clinical investigator the ability to use advanced graphical techniques to help generate and evaluate hypotheses about the data. The major health-related contribution is hoped to be an increase in the ability of the clinician to perceive subtle trends and interrelationships in patient data. Our experience in Phase I will become the basis of a Phase II proposal to develop a prototype software product for wider evaluation and validation. The proposed software has strong commercial appeal in providing more powerful information-handling capabilities to investigators in clinical studies and clinical trials worldwide.

这项研究的主要目标是开发专业软件 帮助临床研究者探索复杂，面向时间的工具 临床数据。 在第一阶段，我们计划与调查人员合作 从发展流行病学网络中选择数据分析， 摘要和显示适合其研究的技术 以原型形式实施这些技术并评估其实用性 与大型新生儿测量数据库有关。 预计该项目的主要技术创新将是 开发面向对象的软件系统，可以处理 临床数据的完全复杂性，并为临床研究者提供 能够使用高级图形技术来帮助生成和 评估有关数据的假设。 主要与健康有关的主要 希望贡献能够提高临床医生的能力 感知患者数据中的微妙趋势和相互关系。 我们在阶段我将成为第二阶段提案的基础 开发原型软件产品，以进行更广泛的评估和 验证。 拟议的软件具有强烈的商业吸引力 提供更强大的信息处理功能 全球临床研究和临床试验的研究者。